Cardiovascular Morbidity and Mortality Attributable to Potentially Inappropriate Medication Use Among Primary Prevention Populations - China, 2015-2023.

Zhenping Zhao, Mei Zhang, Limin Wang, Maigeng Zhou

Abstract read

In one paragraph

Article in China CDC weekly, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it

0cells of the map it votes in

0citing papers in PubMed

–field-weighted citation impact

1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Zhenping ZhaoNational Center for Chronic and Noncommunicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, China.

Mei ZhangNational Center for Chronic and Noncommunicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, China.

Limin WangNational Center for Chronic and Noncommunicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, China.

Maigeng ZhouNational Center for Chronic and Noncommunicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

What is already known about this topic?: Potentially inappropriate medication (PIM) use is a global challenge. The World Health Organization's 2017 What is added by this report?: This study found that from 2015 to 2023, the prevalence of PIM use and the associated cardiovascular disease mortality and morbidity nearly halved. Nonetheless, substantial disparities persist across sex, age, urban-rural status, and geographic region. Inner Mongolia and Tianjin exhibited the most pronounced reductions after 2018. What are the implications for public health practice?: Develop population-based systems to monitor medication use. Integrate rational-use training and public education into essential public health services, and strengthen implementation at the primary care level, particularly in northern and northeastern provinces.

Indexed as

cardiovascular diseasemorbiditymortalitypotential inappropriate medication

Identifiers

PMID41321339

DOI10.46234/ccdcw2025.247

PMCPMC12660141

What OpenQuestion holds

Textmetadata

Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.